<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30233214</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1178-6930</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>11</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>OncoTargets and therapy</Title>                <ISOAbbreviation>Onco Targets Ther</ISOAbbreviation>            </Journal>            <ArticleTitle>Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma.</ArticleTitle>            <Pagination>                <MedlinePgn>5535-5544</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.2147/OTT.S171881</ELocationID>            <Abstract>                <AbstractText Label="Objectives" NlmCategory="UNASSIGNED">The aim of this study was to establish comprehensive and practical nomograms, based on significant clinicopathological parameters, for predicting the overall survival (OS) and the disease-specific survival (DSS) of patients with clear cell renal cell carcinoma (ccRCC).</AbstractText>                <AbstractText Label="Patients and methods" NlmCategory="UNASSIGNED">The data of 35,151 ccRCC patients, diagnosed between 2004 and 2014, were obtained from the database of the Surveillance, Epidemiology, and End Results (SEER) program. The Kaplan-Meier method and Cox proportional hazards regression model were used to evaluate the prognostic effects of multiple clinicopathological variables on survival. Based on Cox models, a nomogram was constructed to predict the probabilities of OS and DSS for an individual patient. The predictive performance of nomograms was evaluated using the concordance index (<i>C</i>-index) and calibration curves.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">According to univariate and multivariate analyses, age at diagnosis, sex, race, marital status, surgical approach, tumor node metastasis (TNM) stage, and Fuhrman grade significantly correlated with the survival outcomes. These characteristics were used to establish nomograms. The nomograms showed good accuracy in predicting 3-, 5-, and 10-year OS and DSS, with a <i>C</i>-index of 0.79 (95% CI, 0.79-0.80) for OS and 0.87 (95% CI, 0.86-0.88) for DSS. All calibration curves revealed excellent consistency between predicted and actual survival.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Nomograms were developed to predict death from ccRCC treated with nephrectomy. These new prognostic tools could aid in improving the predictive accuracy of survival outcomes, thus leading to reasonable individualized treatment.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Guanghao</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Financial Mathematics and Financial Engineering, School of Ecomonics, Shandong University, Jinan, Shandong, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wu</LastName>                    <ForeName>Yun</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Jiashu</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fang</LastName>                    <ForeName>Zhiqing</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China, doctor_fangzq@126.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Zhaoxu</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China, doctor_fangzq@126.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xu</LastName>                    <ForeName>Zhonghua</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China, doctor_fangzq@126.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fan</LastName>                    <ForeName>Yidong</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China, doctor_fangzq@126.com.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>06</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>New Zealand</Country>            <MedlineTA>Onco Targets Ther</MedlineTA>            <NlmUniqueID>101514322</NlmUniqueID>            <ISSNLinking>1178-6930</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2005 Jan 1;103(1):68-75</RefSource>                <PMID Version="1">15573369</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2009 Jan;181(1):55-61; discussion 61-2</RefSource>                <PMID Version="1">19012918</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Mar 1;136(5):E359-86</RefSource>                <PMID Version="1">25220842</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Urol. 2015 May;67(5):913-24</RefSource>                <PMID Version="1">25616710</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urol Clin North Am. 2008 Nov;35(4):551-61; v</RefSource>                <PMID Version="1">18992609</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stat Med. 1996 Feb 28;15(4):361-87</RefSource>                <PMID Version="1">8668867</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Oct 20;10(10):e0140257</RefSource>                <PMID Version="1">26484545</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urology. 2002 Apr;59(4):532-7</RefSource>                <PMID Version="1">11927308</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2010 Apr;183(4):1309-15</RefSource>                <PMID Version="1">20171681</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2002 Oct;41(4):283-300</RefSource>                <PMID Version="1">12383210</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2009 Mar 28;373(9669):1119-32</RefSource>                <PMID Version="1">19269025</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2006 Apr;175(4):1235-9</RefSource>                <PMID Version="1">16515968</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2018 Apr;97(16):e0385</RefSource>                <PMID Version="1">29668592</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Urol. 2013 Oct;31(5):1073-80</RefSource>                <PMID Version="1">23568445</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Support Oncol. 2003 Nov-Dec;1(4 Suppl 2):25-9</RefSource>                <PMID Version="1">15346997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2000 Feb;163(2):426-30</RefSource>                <PMID Version="1">10647646</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Urol. 2014 Feb;65(2):372-7</RefSource>                <PMID Version="1">23850254</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2008 Oct;180(4):1290-5; discussion 1295-6</RefSource>                <PMID Version="1">18707704</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2012 Jul;188(1):51-7</RefSource>                <PMID Version="1">22591957</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2001 Jan 15;91(2):354-61</RefSource>                <PMID Version="1">11180082</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2000 Aug 1;89(3):604-14</RefSource>                <PMID Version="1">10931460</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BJU Int. 2014 Nov;114(5):708-18</RefSource>                <PMID Version="1">24274650</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2016 May 24;6:26684</RefSource>                <PMID Version="1">27215834</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Surg Pathol. 2003 May;27(5):612-24</RefSource>                <PMID Version="1">12717246</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1997 Sep 1;80(5):987-9</RefSource>                <PMID Version="1">9307203</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Urol. 2017 Apr;71(4):606-617</RefSource>                <PMID Version="1">27614693</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 May 16;8(42):71797-71804</RefSource>                <PMID Version="1">29069747</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urol Oncol. 2008 May-Jun;26(3):225-38</RefSource>                <PMID Version="1">18452811</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2005 Jan;173(1):48-51</RefSource>                <PMID Version="1">15592023</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urol Oncol. 2014 Jan;32(1):30.e9-13</RefSource>                <PMID Version="1">23422777</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2006 Dec 1;107(11):2604-8</RefSource>                <PMID Version="1">17075871</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2005 Oct 1;104(7):1362-71</RefSource>                <PMID Version="1">16116599</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2008 May;179(5):1704-8</RefSource>                <PMID Version="1">18343443</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Surg Pathol. 2002 Mar;26(3):281-91</RefSource>                <PMID Version="1">11859199</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer J. 2008 Sep-Oct;14(5):288-301</RefSource>                <PMID Version="1">18836333</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2002 Dec 1;20(23):4559-66</RefSource>                <PMID Version="1">12454113</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Scand J Urol Nephrol. 2002;36(6):414-8</RefSource>                <PMID Version="1">12623504</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2007 Apr 10;25(11):1316-22</RefSource>                <PMID Version="1">17416852</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2005 Apr 20;23(12):2763-71</RefSource>                <PMID Version="1">15837991</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2009 Apr 1;115(7):1465-71</RefSource>                <PMID Version="1">19195042</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2001 Mar 15;19(6):1649-57</RefSource>                <PMID Version="1">11250993</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2006 Sep;7(9):735-40</RefSource>                <PMID Version="1">16945768</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Urol. 2008 Jul;54(1):133-40</RefSource>                <PMID Version="1">18160207</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Urol. 2010 Jan;57(1):102-9</RefSource>                <PMID Version="1">19062157</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urology. 2009 Jan;73(1):137-41</RefSource>                <PMID Version="1">18950844</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Urol. 2015 Jan;67(1):85-97</RefSource>                <PMID Version="1">24857407</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2008 May;34(3):193-205</RefSource>                <PMID Version="1">18313224</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2002 Dec;168(6):2395-400</RefSource>                <PMID Version="1">12441925</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2004 Aug 15;22(16):3316-22</RefSource>                <PMID Version="1">15310775</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urology. 2017 Feb;100:151-157</RefSource>                <PMID Version="1">27889493</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathology. 2007 Oct;39(5):459-65</RefSource>                <PMID Version="1">17886093</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Public Health. 2014 Jun;104 Suppl 3:S396-403</RefSource>                <PMID Version="1">24754655</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Surg Oncol. 2007 Feb 05;5:16</RefSource>                <PMID Version="1">17280613</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2001 Jul;166(1):63-7</RefSource>                <PMID Version="1">11435824</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urol Oncol. 2002 Jul-Aug;7(4):135-40</RefSource>                <PMID Version="1">12474528</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Urol. 2005 Oct;48(4):593-600</RefSource>                <PMID Version="1">15964127</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Urol Oncol. 2002 May;20(2):108-15</RefSource>                <PMID Version="1">12012296</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Urol. 2011 Jan;18(1):20-31</RefSource>                <PMID Version="1">21077960</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2016 Dec 12;6:39028</RefSource>                <PMID Version="1">27941905</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">clear cell renal cell carcinoma</Keyword>            <Keyword MajorTopicYN="N">nomogram</Keyword>            <Keyword MajorTopicYN="N">prognosis</Keyword>            <Keyword MajorTopicYN="N">survival analysis</Keyword>        </KeywordList>        <CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30233214</ArticleId>            <ArticleId IdType="doi">10.2147/OTT.S171881</ArticleId>            <ArticleId IdType="pii">ott-11-5535</ArticleId>            <ArticleId IdType="pmc">PMC6134959</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>